期刊中心


Sensitivity and Specificity: DSM-IV Versus DSM-5 Criteria for Autism Spectrum Disorder
Luke Y. Tsai, M.D.
Does Concomitant Use of NSAIDs Reduce the Effectiveness of Antidepressants?
Richard C. Shelton, M.D.
Substance-Specific Symptoms and General Liability to Addiction
Michael M. Vanyukov, Ph.D.
Brain Development and Schizophrenia
Robert Freedman, M.D.
Advertisement
In This Issue
CME    Toward Systems Neuroscience of ADHD: A Meta-Analysis of 55 fMRI Studies
Samuele Cortese, M.D., Ph.D.; Clare Kelly, Ph.D.; Camille Chabernaud, Ph.D.; Erika Proal, Ph.D.; Adriana Di Martino, M.D.; Michael P. Milham, M.D., Ph.D.; F. Xavier Castellanos, M.D.
Application of DSM-5 Criteria for Autism Spectrum Disorder to Three Samples of Children With DSM-IV Diagnoses of Pervasive Developmental Disorders
Marisela Huerta, Ph.D.; Somer L. Bishop, Ph.D.; Amie Duncan, Ph.D.; Vanessa Hus, M.Sc.; Catherine Lord, Ph.D.
CME    Antidepressant Response in Patients With Major Depression Exposed to NSAIDs: A Pharmacovigilance Study
Patience J. Gallagher, B.S.; Victor Castro, B.S.; Maurizio Fava, M.D.; Jeffrey B. Weilburg, M.D.; Shawn N. Murphy, M.D., Ph.D.; Vivian S. Gainer, M.S.; Susanne E. Churchill, Ph.D.; Isaac S. Kohane, M.D., Ph.D.; Dan V. Iosifescu, M.D., M.Sc.; Jordan W. Smoller, M.D., Sc.D.; Roy H. Perlis, M.D., M.Sc.
Decline in Genetic Influence on the Co-Occurrence of Alcohol, Marijuana, and Nicotine Dependence Symptoms From Age 14 to 29
Scott I. Vrieze, M.A.; Brian M. Hicks, Ph.D.; William G. Iacono, Ph.D.; Matt McGue, Ph.D.
Deficits in Transcriptional Regulators of Cortical Parvalbumin Neurons in Schizophrenia
David W. Volk, M.D., Ph.D.; Takurou Matsubara, M.D.; Siyu Li, M.A.; Elizabeth J. Sengupta, M.A.; Danko Georgiev, M.D., Ph.D.; Yoshio Minabe, M.D., Ph.D.; Allan Sampson, Ph.D.; Takanori Hashimoto, M.D., Ph.D.; David A. Lewis, M.D.
Thalamocortical Dysconnectivity in Schizophrenia
Neil D. Woodward, Ph.D.; Haleh Karbasforoushan, M.S.; Stephan Heckers, M.D., M.Sc.
Presupplementary Motor Area Hyperactivity During Response Inhibition: A Candidate Endophenotype of Obsessive-Compulsive Disorder
Stella J. de Wit, M.D.; Froukje E. de Vries, M.D.; Ysbrand D. van der Werf, Ph.D.; Danielle C. Cath, M.D., Ph.D.; Dirk J. Heslenfeld, Ph.D.; Eveline M. Veltman, M.Sc.; Anton J.L.M. van Balkom, M.D., Ph.D.; Dick J. Veltman, M.D., Ph.D.; Odile A. van den Heuvel, M.D., Ph.D.
Amygdala Response to Preattentive Masked Fear in Children With Conduct Problems: The Role of Callous-Unemotional Traits
Essi Viding, Ph.D.; Catherine L. Sebastian, Ph.D.; Mark R. Dadds, Ph.D.; Patricia L. Lockwood, B.Sc.; Charlotte A.M. Cecil, M.Sc.; Stephane A. De Brito, Ph.D.; Eamon J. McCrory, D.Clin.Psych., Ph.D.
CME    The Changing “Weightscape” of Bulimia Nervosa
Cynthia M. Bulik, Ph.D.; Marsha D. Marcus, Ph.D.; Stephanie Zerwas, Ph.D.; Michele D. Levine, Ph.D.; Maria La Via, M.D.
Age at Migration and Risk of Schizophrenia Among Immigrants in Denmark: A 25-Year Incidence Study
Carsten bøcker Pedersen, Dr.Med.Sc.; Elizabeth Cantor-graae, Ph.D.
Deficiency of the Odds Ratio for Common Outcomes
Jay S. Kaufman, Ph.D.; Sam Harper, Ph.D.
Response to Kaufman and Harper Letter
Li-Shiun Chen, M.D., M.P.H., Sc.D.; Timothy B. Baker, Ph.D.; Laura J. Bierut, M.D.
Research on Medical Marijuana
IGOR GRANT, M.D.; J. HAMPTON ATKINSON, M.D.; BEN GOUAUX, B.A.
Response to Grant et al. Letter
Herbert D. Kleber, M.D.; Robert L. DuPont, M.D.
Serum IgG Antibodies Against the NR1 Subunit of the NMDA Receptor Not Detected in Schizophrenia
Joseph C. Masdeu, M.D., Ph.D.; Ana GonzÁLez-Pinto, M.D., Ph.D.; Carlos Matute, Ph.D.; Sonia Ruiz De AzÚa, Ph.D.; A. Palomino, Ph.D.; Jose De Leon, M.D.; Karen F. Berman, M.D.; Josep Dalmau, M.D., Ph.D.
The Massachusetts Mental Health Center: Going Forward After 100 Years
Carl Salzman, M.D.; Larry J. Seidman, Ph.D.; Matcheri S. Keshavan, M.D.
Books Received
Presidential Address
John M. Oldham, M.D., M.S.
Response to the Presidential Addresses
Dilip V. Jeste, M.D.
John M. Oldham, M.D., M.S., 138th President, 2011–2012
Robert Michels, M.D.